Patient perspective: Fatigue as a recommended patient centered outcome measure in rheumatoid arthritis

Journal of Rheumatology

Volumn 34, Issue 5, 2007, Pages 1174-1177

  Kirwan, John R ^a   Minnock, Patricia ^b   Adebajo, Ade ^c   Bresnihan, Barry ^b   Choy, Ernest ^d   De Wit, Maarten ^e   Hazes, Mieke ^f   Richards, Pam ^a   Saag, Kenneth ^g   Suarez Almazor, Maria ^h   Wells, George ⁱ   Hewlett, Sarah ^j  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e Dutch Arthritis Patients' League   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g The University of Alabama at Birmingham   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

^j UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

more..

Author keywords

Fatigue; Outcomes; Patient centered; Rheumatoid arthritis; Validity

Indexed keywords

CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; FATIGUE; HEALTH CARE PERSONNEL; HUMAN; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VALIDITY;

ARTHRITIS, RHEUMATOID; ENDPOINT DETERMINATION; FATIGUE; HUMANS; INTERNATIONAL COOPERATION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY; TREATMENT OUTCOME;

EID: 34248648440     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.
2. Kirwan JR, Hewlett S. Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis. J Rheumatol 2007;34:1171-3.
3. Kirwan J, Heiberg T, Hewlett S, et al. Outcomes from the patient perspective workshop at OMERACT 6. J Rheumatol 2003;30:868-72.
4. Kirwan JR, Hewlett S, Heiberg T, et al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis - progress at OMERACT 7. J Rheumatol 2005;32:2250-6.
5. Minnock P, Bresnihan B. Pain outcome and fatigue levels reported by women with established rheumatoid arthritis [abstract]. Arthritis Rheum 2004;50 Suppl:S471.
6. Carr A, Hewlett S, Hughes R, et al. Rheumatology outcomes: the patient's perspective. J Rheumatol 2003;30:880-3.
7. Ahlmen M, Nordenskiold U, Archenholtz B, et al. Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology Oxford 2005;44:105-10.
8. Hewlett S, Cockshot Z, Byron M, et al. Patients' perceptions of fatigue in rheumatoid arthritis: Overwhelming, uncontrollable, ignored. Arthritis Care Res 2005;53:697-702.
9. Hewlett S, Carr M, Ryan S, et al. Outcomes generated by patients with rheumatoid arthritis: how important are they? Musculoskeletal Care 2005;3:131-42.
10. Hewlett S, Hehir M, Kirwan JR. Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Care Res 2007; (in press).
11. Tack BB. Dimensions and correlates of fatigue in older adults with rheumatoid arthritis [PhD dissertation]. San Francisco: University Of California, San Francisco; 1991.
12. Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005;32:811-9.
13. Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor-a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate. Arthritis Rheum 2003;48:35-45.
14. Russell AS, Conner-Spady B, Mintz A, Mallon C, Maksymowych WP. The responsiveness of generic health status measures assessed in patients with rheumatoid arthritis receiving infliximab. J Rheumatol 2003;30:941-7.
15. Sinclair VG, Wallston KA, Dwyer KA, Balckburn DS, Fuchs H. Effects of a cognitive-behavioral intervention for women with rheumatoid arthritis. Res Nursing Health 1998;21:315-26.
16. Evers A, Kraaimaat F, van Riel P, de Jong A. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain 2002;100:141-53.
17. Kaltwasser JP, Kessler U, Gottschalk R, Stucki G, Möller B. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol 2001;28:2430-6.
18. Daltroy LH, Robb-Nicholson C, Iversen MD, Wright EA, Liang MH. Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. Br J Rheumatol 1995;34:1064-9.
19. Neuberger GB, Press AN, Lindsley HB, et al. Effects of exercise on fatigue, aerobic fitness, and disease activity measures in persons with rheumatoid arthritis. Res Nursing Health 1997;20:195-204.
20. Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology Oxford 2006;45:885-9.
21. Boers M, Tugwell P, Felson DT, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol 1994;21 Suppl 41:86-9.
22. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.